|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Omnicef (cefdinir) Capsules, Abbott NDA 50-739/S-006 7/24/02 8/6/02 Omnicef (cefdinir) Capsules, Parke-Davis NDA 50-739/S-002 11/24/99 12/30/99 12/30/99 Omnicef (cefdinir) Powder Suspension Parke-Davis NDA 50-749/SE2-002 7/14/99 7/29/99 7/29/99 Omnicef Indication: 5-day dosing regimen (7 mg/kg BID) for the treatment of AOM Omnicef (cefdinir) for Oral Suspension, Abbott Laboratories, Control Supplement Omnicef (cefdinir) capsules, Abbott Laboratories, Labeling Revision | Omnicef (cefdinir) capsules, Abbott Laboratories, Labeling Revision | Omnicef (cefdinir) powder for oral suspension, Abbott Laboratories, Labeling Revision | Cefdinir Capsules, Lupin Ltd., Approval | Cefdinir Oral Suspension, Lupin Ltd., Approval
|